A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

By Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1115-1121

Informa Healthcare

Access to resources Recommend Favorite

Cost–utility comparison of escitalopram and sertraline in the treatment of major depressive disorder

By Armstrong Edward P.   Skrepnek Grant H.   Haim Erder M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 251-258

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

By Ventura Daniel   Armstrong Edward P.   Skrepnek Grant H.   Haim Erder M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 245-250

Informa Healthcare

Access to resources Recommend Favorite

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population

By Wu Eric   Greenberg Paul E.   Yang Elaine   Yu Andrew   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2587-2595

Informa Healthcare

Access to resources Recommend Favorite

Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder

By  

Psychotherapy and Psychosomatics, Vol. 85, Iss. 3, 2016-04 ,pp. : 171-179

Karger

Access to resources Recommend Favorite